MDxHealth SA Stock Euronext Bruxelles
Equities
MDXH
BE0974461940
Biotechnology & Medical Research
Sales 2023 | 64.39M 68.65M | Sales 2024 * | 73.53M 78.4M | Capitalization | 60.25M 64.24M |
---|---|---|---|---|---|
Net income 2023 | -39M -41.58M | Net income 2024 * | -26M -27.72M | EV / Sales 2023 | 1.51 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.82 x |
P/E ratio 2023 |
-2.37
x | P/E ratio 2024 * |
-2.34
x | Employees | 255 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 97.37% |
Latest transcript on MDxHealth SA
1st Jan change | Capi. | |
---|---|---|
-0.02% | 42.11B | |
+46.00% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |